Dudediligence.

Kiora Pharmaceuticals, Inc

KPRXNASDAQ · Pharmaceutical Preparations
Write an idea

Filings

Newest first

The annual , the quarterly and the filed between them when something material happens.

  1. Sep 1713GPassive stake of 5% or more (13G), filed by Baselake Partners
  2. Sep 88-KOfficer or director change and Regulation FD disclosure5.027.019.01
  3. Aug 198-KMaterial agreement and Regulation FD disclosure1.017.019.01
  4. Aug 1013GPassive stake of 5% or more (13G), filed by Perceptive Advisors
  5. Aug 78-KResults of operations2.029.01
  6. Aug 710-QQuarterly report
  7. Jun 188-KRegulation FD disclosure7.019.01
  8. Jun 108-KOfficer or director change and shareholder vote5.025.079.01
  9. May 28424B3Prospectus for an offering
  10. May 18S-3Shelf registration
  11. May 88-KResults of operations2.029.01
  12. May 810-QQuarterly report
  13. Apr 78-KMaterial agreement and unregistered sale of shares1.013.027.019.01
  14. Apr 28-KOfficer or director change and Regulation FD disclosure5.027.019.01
  15. Mar 258-KResults of operations2.029.01
  16. Mar 2510-KAnnual report
  17. Nov 7, 20258-KResults of operations2.029.01
  18. Nov 7, 202510-QQuarterly report
  19. Sep 15, 2025S-3Shelf registration
  20. Aug 12, 20258-KRegulation FD disclosure7.01
  21. Aug 8, 20258-KResults of operations2.029.01
  22. Aug 8, 202510-QQuarterly report
  23. Jun 4, 20258-KShareholder vote5.079.01
  24. Jun 3, 20258-KMaterial agreement and Regulation FD disclosure1.017.019.01
  25. May 9, 20258-KResults of operations2.029.01
  26. May 9, 202510-QQuarterly report
  27. Mar 25, 20258-KResults of operations2.029.01
  28. Mar 25, 202510-KAnnual report
  29. Jan 15, 20258-KOfficer or director change5.029.01
  30. Nov 8, 20248-KResults of operations2.029.01
  31. Nov 8, 202410-QQuarterly report
  32. Oct 29, 20248-KRegulation FD disclosure7.019.01